Patent details

Basic Information

Publication number:

EP3906066

PCT Application Number:

US2020012131

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP207046335

PCT Publication Number:

WO2020142653

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GENE THERAPY CONSTRUCTS FOR TREATING WILSON DISEASE

French Title of Invention:

CONSTRUCTIONS DE THÉRAPIE GÉNIQUE POUR LE TRAITEMENT DE LA MALADIE DE WILSON

German Title of Invention:

GENTHERAPIEKONSTRUKTE ZUR BEHANDLUNG DER WILSON-KRANKHEIT

SPC Number:

Dates

Filing date:

03/01/2020

Grant date:

01/11/2023

EP Publication Date:

10/11/2021

PCT Publication Date:

09/07/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/11/2023

EP B1 Publication Date:

01/11/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/01/2024

Expiration date:

03/01/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/10/2023

 

 

Name:

Ultragenyx Pharmaceutical Inc.

Address:

60 Leveroni Court, Novato, CA 94949, United States (US)

Inventor

1

Name:

LIVINGSTON, Christine

Address:

United States (US)

2

Name:

WADSWORTH, Samuel

Address:

United States (US)

Priority

1

Priority Number:

201962788324 P

Priority Date:

04/01/2019

Priority Country:

United States (US)

2

Priority Number:

201962834830 P

Priority Date:

16/04/2019

Priority Country:

United States (US)

Classification

IPC classification:

A61K 48/00; C12N 15/86; C12N 9/64;

Publication

European Patent Bulletin

Issue number:

202344

Publication date:

01/11/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages